| 注册
首页|期刊导航|中国医药科学|抗生素和益生菌制剂治疗腹泻型肠易激综合征(IBS-D)的临床研究

抗生素和益生菌制剂治疗腹泻型肠易激综合征(IBS-D)的临床研究

周巍 白珩

中国医药科学Issue(10):74-76,3.
中国医药科学Issue(10):74-76,3.

抗生素和益生菌制剂治疗腹泻型肠易激综合征(IBS-D)的临床研究

Clinical research of antibiotics and probiotics in treatment for IBS-D

周巍 1白珩1

作者信息

  • 1. 辽宁省兴城市人民医院,辽宁兴城 125100
  • 折叠

摘要

Abstract

ObjectiveTo investigate the clinical effect of antibiotics and probiotics in treatment for IBS-D. Methods128 patients with IBS-D were selected in hospital from October 2011 to October 2013. According to treatment, the patients were divided into two groups. 64 patients treated probiotics as control group. 64 patients treated antibiotics and probiotics as observation group. Course of treatment was 8 weeks. Symptom scores were finished in different time points before and after treatment. Therapeutic effect was compared between two groups. Results Symptom scores at 2 weeks,4 weeks,6 weeks,8 weeks in observation group were significantly lower than control group. Total efficiency in observation group(98.44%) was significantly higher than control group(87.50%). Differences were statistically significant(P<0.05).Conclusion Antibiotics and probiotics are effective drugs in treatment for IBS-D, which can significantly improve clinical symptoms and improve therapeutic effect.

关键词

抗生素/益生菌制剂/腹泻型肠易激综合征/症状评分/治疗效果

Key words

Antibiotics/Probiotics/IBS-D/Symptom score/Therapeutic effect

分类

医药卫生

引用本文复制引用

周巍,白珩..抗生素和益生菌制剂治疗腹泻型肠易激综合征(IBS-D)的临床研究[J].中国医药科学,2014,(10):74-76,3.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文